TidalSense
PrivateLast Round
Early Funding
Jul 24, 2026
Total Funding Raised
$22.43M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
TidalSense is a healthcare technology company that develops AI-driven respiratory diagnostic and monitoring tools capable of detecting changes in lung function through real-time conversion of sensor data into respiratory biomarkers.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical AI, Health IoT, Sensors
Business Model
B2B
Customer Profile
Usage-Based SaaS, Hardware + Subscription
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
TidalSense Comparables
Compare TidalSense with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Arete Medical Technologies Ltd | 83% | |
| Alveofit | 79% | |
| Aevice Health | 78% |
TidalSense Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Jul 24, 2026 | ||||
| Grant | Feb 6, 2025 | ||||
| VC Round | May 16, 2023 | ||||
| Seed | Apr 13, 2023 | ||||
| Grant | Jan 4, 2023 | ||||
VC Round | Dec 1, 2020 |
Key People
Founding team and executive leadership
TidalSense Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Foresight Group Holdings Limited | Seed |
| SBRI Healthcare | Grant |
| BGF | VC Round, Early Funding |
| Downing | VC Round |
| Innovate UK | Grant |
| Foresight Group LLP | Early Funding |
| Downing Ventures | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
$19M raised with participation from BGF and Foresight Group LLP.
- Mar 10, 2026
Launched AI-driven diagnostic test for COPD using patented sensor technology.
Recent news
Latest coverage and updates
- is_developingJul 26, 2026
TidalSense Limited is developing AI-driven diagnostic and monitoring technologies for respiratory diseases on Jul 1st '13.
- is_developingJul 24, 2026
TidalSense Limited is developing asthma diagnostic tool on Jul 24th '26.
- hiresJul 24, 2026
TidalSense Limited hires Donna Parr as board.
- hiresJul 24, 2026
TidalSense Limited hires Andrew Wheeler as Director of Market Access and Public Policy.
- launchesJul 24, 2026
TidalSense Limited launched N-Tidal Diagnose on Mar 1st '25.
TidalSense Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about TidalSense's valuation, stock price, and market status.
Is TidalSense a public or private company?
TidalSense is a private company.
What is the current stock price of TidalSense?
TidalSense is a private company with no public stock price. No recent secondary market data is available.
How much is TidalSense worth (valuation)?
Valuation information for TidalSense is not publicly available.
Can I buy TidalSense stock?
TidalSense shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was TidalSense's last funding round?
TidalSense's most recent funding round was Grant on February 6, 2025.
Who are the main investors in TidalSense?
Key investors in TidalSense include BGF, Downing, Downing Ventures.
Will TidalSense IPO soon?
No public IPO plans have been announced for TidalSense.
How can I track TidalSense secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor TidalSense's secondary market activity and sign up for updates.